Group Leader
Diego Arango del Corro
Researchers
Águeda Martínez Barriocanal
PhD Students
Estefanía Anguita Espinosa, Li Jing, Bruno Brotons Morales
Lab Technicians
Mariona Dalmau Längst
3
PUBLICATIONS
100.0%
%Q1
26
IMPACT FACTOR
8.81
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
Luk IY, Jenkins LJ, Schoffer KL, Ng I, Tse JWT, Mouradov D, Kaczmarczyk S, Nightingale R, Burrows AD, Anderson RL, Arango D, Dopeso H, Croft L, Richardson MF, Sieber OM, Liao Y, Mooi JK, Vukelic N, Reehorst CM, Afshar-Sterle S, et al.
Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression.
Cell Death Differ. 2022 Nov;29(11):2288-2302.
DOI: doi: 10.1038/s41418-022-01016-w
IF: 12.073
Carton-Garcia F, Brotons B, Anguita E, Dopeso H, Tarragona J, Nieto R, Garcia-Vidal E, Macaya I, Zagyva Z, Dalmau M, Sanchez-Martin M, van Ijzendoorn SCD, Landolfi S, Hernandez-Losa J, Schwartz S Jr, Matias-Guiu X, Ramon Y Cajal S, Martinez-Barriocanal, Arango D.
Myosin Vb as a tumor suppressor gene in intestinal cancer
Oncogene. 2022 Dec;41(49):5279-5288.
DOI: doi: 10.1038/s41388-022-02508-2
IF: 8.756
Fourniols T, Maggio V, Rafael D, Colaco A, Garcia Vidal E, Lopes A, Schwartz S, Martinez-Barriocanal, Preat V, Arango D.
Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation
Eur J Pharm Biopharm. 2022 Feb;171:39-49.
DOI: doi: 10.1016/j.ejpb.2021.10.017
IF: 5.589
RHOA signaling in gastric cancer: friend or foe?
Principal Investigator: Diego Arango del Corro
Agency: Asociación Española Contra el Cáncer
Funding: 1,015,000€
Period: 2015-2022
Cell-penetrating peptides
Priority Number: EP20382968
Priority Date: 10/11/2020
Applicants: VHIR, CIBER